Patent · US Active

MiRNA signature expression in cancer

US11976330B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

University of Vermont and State Agricultural College · US

Inventors

Marie E. Wood · South Burlington, US
Jane B. Lian · Westborough, US
Nicholas Farina · Sunnyvale, US
Janet L. Stein · Shrewsbury, US

Key dates

Filing date	Apr 6, 2018
Grant date	May 7, 2024
Priority date	—
Expiry date	Aug 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods and kits for detecting cancer-associated miRNA are disclosed herein. Methods of identifying and treating a human patient at risk for cancer are also disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.